| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 362,362,277.00 | 441,230,374.00 | 377,983,655.00 |
| Cash and cash equivalents | 6,131,122.00 | 6,416,028.00 | 6,300,572.00 | 15,538,602.00 |
| Equity | 291,540,191.00 | 270,556,445.00 | 317,660,742.00 | 273,228,406.00 |
| Issued Capital | N/A | 20,300,000.00 | 20,300,000.00 | 20,300,000.00 |
| Retained Earnings | N/A | 21,847,960.00 | 20,615,367.00 | 26,369,664.00 |
| Share Premium | N/A | 161,040,000.00 | 161,040,000.00 | 161,040,000.00 |
| Other Reserves | N/A | N/A | 112,779,146.00 | 112,779,146.00 |
| Capital Reserve | N/A | -50,393,578.00 | 1,667,026.00 | -48,473,649.00 |
| Equity Attributable To Owners Of Parent | N/A | 270,537,108.00 | 317,614,784.00 | 273,228,406.00 |
| Noncontrolling Interests | N/A | 19,337.00 | 45,958.00 | 0.00 |
| Liabilities | N/A | 91,805,832.00 | 123,569,632.00 | 104,755,249.00 |
| Line item in (gbp) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 40,655,383.00 | 102,643,391.00 | -2,832,379.00 |
| Revenue From Interest | 35,979,958.00 | 33,158,150.00 | 33,917,279.00 |
| Other Revenue | N/A | 4,419,620.00 | 7,418,009.00 |
| Other Income | 5,799,767.00 | 4,419,620.00 | N/A |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 112,550.00 | 3,636,142.00 | 5,956,807.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 112,550.00 | 3,636,142.00 | 5,956,807.00 |
| Other Expense By Nature | 2,545,805.00 | 3,372,075.00 | 2,432,132.00 |
| Finance Costs | 7,607,524.00 | 5,706,429.00 | 7,046,478.00 |
| Profit Loss Before Tax | 22,954,679.00 | 73,213,368.00 | -22,108,066.00 |
| Income Tax Expense Continuing Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | 22,954,679.00 | 73,213,368.00 | -22,108,066.00 |
| Profit Loss Attributable To Owners Of Parent | 22,879,629.00 | 73,183,772.00 | -22,124,267.00 |
| Profit Loss Attributable To Noncontrolling Interests | 75,050.00 | 29,596.00 | 16,201.00 |
| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 22,954,679.00 | 73,213,368.00 | -22,108,066.00 |
| Adjustments For Finance Costs | N/A | 7,607,524.00 | 5,706,429.00 | 7,046,478.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | N/A | 3,636,142.00 | 5,956,807.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | 2,970,304.00 | 2,049,374.00 | 1,552,676.00 |
| Adjustments For Fair Value Gains Losses | N/A | N/A | -67,354,436.00 | 20,298,529.00 |
| Interest Received Classified As Operating Activities | N/A | 37,597,261.00 | 32,062,716.00 | 32,776,781.00 |
| Cash Flows From Used In Operating Activities | N/A | 77,236,639.00 | 29,273,502.00 | 50,703,055.00 |
| Cash Flows From Used In Investing Activities | N/A | -2,477,357.00 | -19,075,940.00 | -43,893.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 20,213,722.00 | 3,741,814.00 | 0.00 |
| Dividends Paid Classified As Financing Activities | N/A | 23,674,744.00 | 22,355,761.00 | 22,262,111.00 |
| Interest Paid Classified As Financing Activities | N/A | 7,165,276.00 | 5,739,082.00 | 6,840,222.00 |
| Cash Flows From Used In Financing Activities | N/A | -74,680,178.00 | -10,656,580.00 | -54,585,694.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 79,104.00 | -459,018.00 | -3,926,531.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 205,802.00 | 343,562.00 | 13,164,561.00 |
| Cash and cash equivalents | 6,131,122.00 | 6,416,028.00 | 6,300,572.00 | 15,538,602.00 |
Please note that some sums might not add up.
GB00BVG6X439
549300UPEXC5DQB81P34
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.
